Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
662.00    8.00 (1.22%)
Bid:
663.00
Ask:
668.00
Spread: 5.00 (0.754%)
Market Cap: £636.36m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Trading Update

13 Oct 2016 07:00

RNS Number : 3969M
Acal PLC
13 October 2016
 

For Release

7.00am, 13 October 2016

Acal plc

First Half Trading Update

 

Acal plc (LSE: ACL, "Acal" or "the Group"), one of the leading international suppliers of customised electronics to industry, today issues a trading update for the six months ended 30 September 2016 ahead of publishing its half-year results on 29 November 2016.

 

For the first half, the Group expects to report further good progress with double digit growth in underlying operating profit as anticipated. Orders were 18% higher than the previous year, and sales 10% higher. In the Design & Manufacturing division, sales were 24% higher and in Custom Distribution 2% lower. Our outlook for the year remains unchanged.

 

The business continues to perform well despite the general economic uncertainty. As anticipated and reported in July, first half organic sales were slower. However, as gross margins have remained robust along with tight cost control, profitability levels have been maintained.

 

Since the first quarter, orders have increased and are showing good levels of organic growth in line with our expectations of achieving stronger sales in the second half of the year. Second quarter orders grew organically by 3% over the prior year and September order intake was better than expected being 6% higher than prior year. First half Group organic orders and sales were 1% and 8% lower respectively.

 

Given the international nature of the Group's business, we are benefitting from the translation effect of Sterling's decline in value since the end of June1 partly offset by the impact of higher US Dollar purchases.

 

As part of our ongoing focus on efficiency improvements, a restructuring programme is being implemented in the Custom Distribution division that will reduce management numbers, close one unprofitable business subsidiary in Europe and reduce administrative costs whilst maintaining customer and sales focus. This is in addition to the previously announced actions that have resulted in the closure of three small Nordic production sites and the further integration of purchasing and production processes in the Design & Manufacturing division.

In total, these actions, which are being implemented during the current financial year, are expected to achieve cost savings of £4m per annum and deliver sustained profitability improvements next year and beyond. A one off associated exceptional cost of around £8m is expected to be incurred this year relating primarily to people and property costs.

 

Acquisitions remain an important part of the Group's growth strategy and we have a pipeline of opportunities that are progressing well.

 

The Board remains confident in our future prospects as we continue to execute our strategy and we look forward to further updating shareholders at our interim results in November.

 

For further information please contact:

Acal plc 01483 544 500

Nick Jefferies - Group Chief Executive

Simon Gibbins - Group Finance Director

 

Instinctif Partners 020 7457 2020

Mark Garraway

Helen Tarbet

James Gray

 

Notes to First Half Trading Update

1. The average sterling rate of exchange weakened 12% against the Euro for the 6 months ended 30 September 2016 compared with the average rate for the first half last year (falling from €1.39 to €1.226), weakened 11% against the US Dollar and weakened 10% against Nordic currencies on average

 

2. All growth rates are against the equivalent prior year period unless stated.

 

3. Organic growth for the Group is calculated at Constant Exchange Rates ("CER"), including the pre-acquisition periods of the Flux Group, Contour, and Plitron which were acquired last financial year (on 5 November 2015, 7 January 2016 and 1 February 2016 respectively).

 

4. The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

About Acal plc

 

Acal is a leading international supplier of customised electronics to industry. It designs, manufactures and distributes customer-specific electronic products and solutions to 25,000 industrial manufacturers and is listed on the London Stock Exchange (LSE: ACL).

 

Acal has two divisions: Design & Manufacturing and Custom Distribution. The majority of its sales comes from products and solutions which are created specifically for a customer. Acal works across a range of technologies, namely Communications & Sensors, Power & Magnetics, Electromechanical & Shielding, Embedded Systems, and Photonics & Imaging.

 

Acal operates through the following wholly-owned businesses: Acal BFi, Contour, Flux, Foss, Hectronic, MTC, Myrra, Noratel, Plitron, RSG, Stortech and Vertec. It has operating companies and manufacturing facilities in a number of markets, including the UK, Germany, France, the Nordic region, Benelux, Italy, Poland, Slovakia and Spain, as well as in Asia (China, India, South Korea, Sri Lanka and Thailand), North America (the US and Canada), and South Africa.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKBDKABDDPKD
Date   Source Headline
3rd Jun 20217:00 amRNSPreliminary results
18th May 20219:01 amRNSHolding(s) in Company
10th May 20215:33 pmRNSHolding(s) in Company
20th Apr 20217:00 amRNSFull Year Trading Update
22nd Feb 20215:26 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSAcquisition completion - Limitor GmbH
9th Feb 202112:08 pmRNSHolding(s) in Company
9th Feb 20217:00 amRNSTrading Update
27th Jan 20217:52 amRNSHolding(s) in Company
10th Dec 20208:53 amEQSdiscoverIE Group (DSCV): Another brick in the yellow wall
7th Dec 20204:42 pmRNSHolding(s) in Company
4th Dec 20207:00 amRNSAcquisition of Limitor GmbH
30th Nov 20207:00 amRNSHalf-Year Report
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
23rd Oct 20209:42 amRNSHolding(s) in Company
16th Oct 20201:23 pmRNSHolding(s) in Company
15th Oct 20205:01 pmRNSHolding(s) in Company
15th Oct 20207:00 amRNSTrading Update
12th Oct 20209:13 amRNSNOTIFICATION OF MAJOR HOLDINGS
8th Oct 20207:00 amRNSNotice of Trading Update & Half Year Results
26th Aug 20204:03 pmRNSHolding(s) in Company
19th Aug 202012:00 pmRNSResult of AGM
30th Jul 20207:00 amRNSTrading Update
28th Jul 20205:45 pmRNSDirector Declarations
28th Jul 20204:00 pmRNSHolding(s) in Company
27th Jul 202010:00 amRNSHolding(s) in Company
15th Jul 202011:00 amRNSAnnual Report and AGM Notice
14th Jul 202010:00 amRNSHolding(s) in Company
13th Jul 20204:15 pmRNSHolding(s) in Company
13th Jul 20204:00 pmRNSHolding(s) in Company
7th Jul 20209:00 amRNSHolding(s) in Company
3rd Jul 20209:00 amRNSHolding(s) in Company
1st Jul 20205:45 pmRNSDirector LTIP Award
30th Jun 20206:00 pmRNSHolding(s) in Company
30th Jun 20208:00 amRNSHolding(s) in Company
24th Jun 20207:00 amRNSFinal Results
3rd Jun 20201:24 pmRNSHolding(s) in Company
15th May 20207:00 amRNSYear-end & Covid-19 Trading Update
14th May 20204:05 pmRNSDirector Declaration
21st Apr 20201:00 pmRNSDirector Declaration
14th Apr 202010:19 amRNSHolding(s) in Company
9th Apr 202012:35 pmRNSHolding(s) in Company
7th Apr 20201:45 pmRNSIssue of Equity & Total Voting Rights
20th Mar 20204:42 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSYear End Trading Update
11th Mar 20203:04 pmRNSHolding(s) in Company
11th Mar 20201:49 pmRNSDirector/PDMR transaction notification
19th Feb 20207:03 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.